1

MEDICAL PUBLICATION
CONFERENCES AND SEMINARS
MARKETING RESEARCH

  • Tuberous sclerosis: a clinical case in practice of pediatric nephrologist
en To content Full text of article

Tuberous sclerosis: a clinical case in practice of pediatric nephrologist

Modern Pediatrics.Ukraine.2020.2(106):100-103; doi 10.15574/SP.2020.106.100
Dudnyk V.1, Zvenigorodska G.1, Andrikevych I.1, Mantak H.1, Guminska H.2, Stepankevych T.2
1National Pirogov Memorial Medical University, Vinnytsia, Ukraine
2Vinnytsia Regional Children's Clinical Hospital, Ukraine

For citation: Dudnyk V, Zvenigorodska G, Andrikevych I, Mantak H et al. (2020). Tuberous sclerosis: a clinical case in practice of pediatric nephrologist. Modern Pediatrics. Ukraine. 2(106): 100-103. doi 10.15574/SP.2020.106.100
Article received: Nov 04, 2019. Accepted for publication: Feb 20, 2020.

Tuberous sclerosis is a genetic disease with multiple organs involvement and the formation of benign tumors. Diagnostic difficulties are associated with variability of clinical manifestations.
Clinical case. The own clinical observation of a patient with tuberous sclerosis with predominant lesions of the kidneys, liver, central nervous system and skin is presented. Physicians' awareness of primary and secondary diagnostic criteria, the use of additional instrumental methods, and genetic counseling contribute to the early diagnosis of the disease and prevent the development of complications.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institution. The informed consent of the patient was obtained for conducting the studies
No conflict of interest was declared by the authors.
Key words: tuberous sclerosis, tumors, children, diagnostic criteria.

REFERENCES

1. Amin S, Kingswood JC, Bolton PF et al. (2019). The UK guidelines for management and surveillance of Tuberous Sclerosis Complex. An International Journal of Medicine. 5: 171–182.

2. Amin S, Lux A, Calder N et al. (2017). Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol. 59: 612–617. https://doi.org/10.1111/dmcn.13352; PMid:27935023

3. Bissler JJ, Kingswood JC, Radzikowska E et al. (2013). Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST82): a multicentre, randomised, double-blind, placebo controlled trial. Lancet. 381: 817–24. https://doi.org/10.1016/S0140-6736(12)61767-X

4. Cao Y et al. (2017). Radiological appearance of tuberous sclerosis complex: a case report and review of literature. International Journal of Clinical and Experimental Medicine. 10;5: 8282–8287.

5. Cheng TS. (2012). Tuberous sclerosis complex: An update. Hong Kong J Dermatol Venereol. 20: 61–65.

6. Demir HA, Ekici F, Yazal Erdem A et al. (2012). Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma. Pediatrics. 130: e243–7. https://doi.org/10.1542/peds.2011-3476; PMid:22732179

7. Harutunian K, Figueiredo R, Gay8Escoda C. (2011). Tuberous sclerosis complex with oral manifestations: A case report and literature review. Med Oral Patol Oral Cir Bucal. 16: e478–81. https://doi.org/10.4317/medoral.16.e478; PMid:20711158

8. Jankar AN, Palange PB, Purandare VC. (2014). Tuberous sclerosis — A case report. Int J Biomed Res. 5: 649–50. https://doi.org/10.7439/ijbr.v5i10.747

9. Koenig MK, Bell CS, Hebert AA et al. (2018). Efficacy and safety of topical rapamycin in patients with facial angiofibromas secondary to tuberous sclerosis complex: the treatment randomized clinical trial. JAMA Dermatol.154: 773–80. https://doi.org/10.1001/jamadermatol.2018.0464; PMid:29800048 PMCid:PMC6128508

10. McCormack FX, Inoue Y, Moss J et al. (2011). Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 364: 1595–606.

11. Milunsky AI, Ito M, Maher TA et al. (2009). Prenatal molecular diagnosis of tuberous sclerosis complex. Am J Obstet Gynecol. 200;321: e1–6. https://doi.org/10.1016/j.ajog.2008.11.004; PMid:19254590

12. Northrup H, Krueger DA. (2013). Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol.49: 243–54.

13. Sarkar S et al. (2016). Tuberous sclerosis complex: A case report. Contemporary Clinical Dentistry. 7;2: 236–239. https://doi.org/10.4103/0976-237X.183071; PMid:27307675 PMCid:PMC4906871

14. Vries PJ, Whittemore VH, Leclezio L et al. (2015). Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist. Pediatr Neurol. 52(1): 25–35. https://doi.org/10.1016/j.pediatrneurol.2014.10.004; PMid:25532776 PMCid:PMC4427347